Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms

This publication has 43 references indexed in Scilit:

• Cytogenetic and Molecular Genetic Abnormalities in Agnogenic Myeloid Metaplasia
  Seminars in Oncology, 2005
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
  Published by Elsevier ,2005
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
  Nature, 2005
• Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information
  Annals of Hematology, 2005
• Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected*
  British Journal of Haematology, 2002
• A Large Proportion of Patients With a Diagnosis of Essential Thrombocythemia Do Not Have a Clonal Disorder and May Be at Lower Risk of Thrombotic Complications
  Blood, 1999
• The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
  Blood, 1998
• Structural organization of the bcr gene and its role in the Ph′ translocation
  Nature, 1985
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
  Nature, 1973
• Editorial: Some Speculations on the Myeloproliferative Syndromes
  Blood, 1951